Blackstone’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
Other funds holding EPIX
Blackstone's EPIX Position: Q3 2022 in Review
Blackstone sold out of ESSA Pharma (EPIX) in Q3 2022, closing a stake of 2,003,103 shares — an estimated $6.31M sold.
Blackstone first reported a position in EPIX in Q4 2018 and held it in 15 quarters. The position peaked at $104M in Q1 2021. 54 funds tracked by Wall St. Rank hold EPIX as of Q3 2022.
- Blackstone reported no remaining ESSA Pharma position as of Q3 2022 after selling out during the quarter.
- Blackstone sold 2,003,103 ESSA Pharma shares in Q3 2022, an estimated $6.31M.
- Blackstone first reported a position in ESSA Pharma in Q4 2018 and held it in 15 quarters.
- Blackstone's ESSA Pharma position peaked at $104M in Q1 2021.
- 54 funds tracked by Wall St. Rank held ESSA Pharma as of Q3 2022.
Based on Blackstone's 13F filing for Q3 2022, filed 14 Nov 2022.